LAB5196
GBSPCR
Collect
E-swab of gynecological site (vaginal, cervical, rectal, urethral).
Unacceptable Conditions
Nongenital sites; delayed transport; samples not collected on E-swabs; sample not properly identified; incorrect container; insufficient sample volume.
Storage/Transport Temperature
Internal: Deliver to lab immediately.
Offsite: Refrigerate and transport to the lab within one day.
Stability (from collection to initiation)
Ambient temperature or refrigerated - transport immediately to the laboratory.
Remarks
Screening and identification of Group B beta hemolytic Strep only.
Indicate if patient is Penicillin-allergic and if susceptibilities to clindamycin and erythromycin should be performed.
In 2002, the CDC released revised guidelines for the prevention of perinatal Group B streptococcal disease. These guidelines recommend universal prenatal screening for vaginal and rectal Group B streptococcal (GBS) colonization of all pregnant women at 35-37 weeks gestation. Procedures for collecting and processing clinical specimens for GBS culture and performing susceptibility testing to clindamycin and erythromycin are also included in the guidelines.
Performed by
PCL Clinical Laboratory - Molecular Diagnostics/Virology and Microbiology
Performed
Daily
Methodology
Bacterial culture plus real-time polymerase chain reaction (PCR)
Reported
2 days
Synonyms
- LAB5196
- GBSPCR
Interpretive Data
Detected (positive)
Performed by
PCL Clinical Laboratory - Molecular Diagnostics/Virology and Microbiology
CPT Codes
87653
Collection |
LAB5196
GBSPCR
Collect
E-swab of gynecological site (vaginal, cervical, rectal, urethral).
Unacceptable Conditions
Nongenital sites; delayed transport; samples not collected on E-swabs; sample not properly identified; incorrect container; insufficient sample volume.
Storage/Transport Temperature
Internal: Deliver to lab immediately.
Offsite: Refrigerate and transport to the lab within one day.
Stability (from collection to initiation)
Ambient temperature or refrigerated - transport immediately to the laboratory.
Remarks
Screening and identification of Group B beta hemolytic Strep only.
Indicate if patient is Penicillin-allergic and if susceptibilities to clindamycin and erythromycin should be performed.
In 2002, the CDC released revised guidelines for the prevention of perinatal Group B streptococcal disease. These guidelines recommend universal prenatal screening for vaginal and rectal Group B streptococcal (GBS) colonization of all pregnant women at 35-37 weeks gestation. Procedures for collecting and processing clinical specimens for GBS culture and performing susceptibility testing to clindamycin and erythromycin are also included in the guidelines.
Performed by
PCL Clinical Laboratory - Molecular Diagnostics/Virology and Microbiology
Ordering |
Performed
Daily
Methodology
Bacterial culture plus real-time polymerase chain reaction (PCR)
Reported
2 days
Synonyms
- LAB5196
- GBSPCR
Result Interpretation |
Interpretive Data
Detected (positive)
Performed by
PCL Clinical Laboratory - Molecular Diagnostics/Virology and Microbiology
Administrative |
CPT Codes
87653